Post-effective Amendment (investment Company, Rule 485(b)) (485bpos)
17 Julio 2013 - 11:27AM
Edgar (US Regulatory)
As filed with the Securities and Exchange Commission on July 17, 2013
Securities Act File No. 333-180881
Investment Company Act File No. 811-22701
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM N-1A
|
|
|
|
|
|
|
|
|
REGISTRATION STATEMENT UNDER THE
SECURITIES ACT OF 1933
|
|
[X]
|
|
|
|
Pre-Effective Amendment No.
|
|
|
|
|
|
Post-Effective Amendment No. 5
|
|
[X]
|
|
|
|
|
|
|
|
and/or
|
|
|
|
|
|
|
|
|
|
REGISTRATION STATEMENT UNDER THE
INVESTMENT COMPANY ACT OF 1940
|
|
[X]
|
|
|
|
Amendment No. 6
|
|
[X]
|
(Check appropriate box or boxes.)
ARDEN INVESTMENT SERIES TRUST
(Exact Name of Registrant as Specified in
Charter)
375 Park Avenue, 32nd Floor
New York, NY 10152
(Address of Principal Executive Offices)
Registrant’s Telephone Number, including Area Code: (212) 751-5252
Henry P. Davis
Arden Asset Management LLC
375 Park Avenue
32nd Floor
New York, New York 10152
(Name and Address of Agent for Service)
Copy to:
George M. Silfen, Esq.
Kramer Levin Naftalis & Frankel LLP
1177 Avenue of the Americas
New York, NY 10036
It is proposed that this filing will become effective (check appropriate box)
|
|
[x]
|
immediately upon filing pursuant to paragraph (b)
|
|
|
[ ]
|
on (date) pursuant to paragraph (b)
|
|
|
[ ]
|
60 days after filing pursuant to paragraph (a)(1)
|
|
|
[ ]
|
on (date) pursuant to paragraph (a)(1)
|
|
|
[ ]
|
75 days after filing pursuant to paragraph (a)(2)
|
|
|
[ ]
|
on (date) pursuant to paragraph (a)(2) of rule 485
|
If appropriate, check the following box:
|
|
[ ]
|
this post-effective amendment designates a new effective date for a previously filed post-effective amendment.
|
SIGNATURES
Pursuant to the requirements of the Securities Act of 1933, as amended, and the Investment Company Act of 1940, as
amended, the Registrant certifies that it meets all of the requirements for effectiveness of this Registration Statement under Rule 485(b) of the Securities Act and has duly caused this Registration Statement to be signed on its behalf by the
undersigned, thereunto duly authorized, in the City of New York and State of New York on the 17
th
day of July, 2013.
|
|
|
|
|
Arden Investment Series Trust
|
|
|
|
|
By:
|
|
/s/ Henry P. Davis
|
|
|
|
Henry P. Davis
Trustee, President and Chief Executive Officer
|
Pursuant to the requirements of the Securities Act of 1933, this Registration
Statement has been signed below by the following persons in the capacities and on the dates indicated.
|
|
|
|
|
|
|
|
|
|
|
Signature
|
|
|
|
Title
|
|
|
|
Date
|
|
|
|
|
|
|
|
/s/ Henry P. Davis
Henry P. Davis
|
|
|
|
Trustee, President and Chief
Executive Officer
|
|
|
|
July 17, 2013
|
|
|
|
|
|
|
|
/s/ Charles S. Crow, III*
Charles S. Crow, III
|
|
|
|
Trustee
|
|
|
|
July 17, 2013
|
|
|
|
|
|
|
|
/s/ Richard B. Gross*
Richard B. Gross
|
|
|
|
Trustee
|
|
|
|
July 17, 2013
|
|
|
|
|
|
|
|
/s/ David C. Reed*
David C. Reed
|
|
|
|
Trustee
|
|
|
|
July 17, 2013
|
|
|
|
|
|
|
|
/s/ Andrew Katz*
Andrew Katz
|
|
|
|
Chief Financial Officer
|
|
|
|
July 17, 2013
|
|
*
|
This registration statement has been signed by each of the persons so indicated by the undersigned as attorney in fact.
|
|
|
|
/s/ Henry P. Davis
|
|
Henry P. Davis, Attorney-in-Fact
|
EXHIBIT INDEX
|
|
|
|
|
|
|
|
EX-101.INS
|
|
XBRL Instance Document
|
|
|
|
|
EX-101.SCH
|
|
XBRL Taxonomy Extension Schema Document
|
|
|
|
|
EX-101.CAL
|
|
XBRL Taxonomy Extension Calculation Linkbase
|
|
|
|
|
EX-101.DEF
|
|
XBRL Taxonomy Extension Definition Linkbase
|
|
|
|
|
EX-101.LAB
|
|
XBRL Taxonomy Extension Labels Linkbase
|
|
|
|
|
EX-101.PRE
|
|
XBRL Taxonomy Extension Presentation Linkbase
|
Helix Biomedix (PK) (USOTC:HXBM)
Gráfica de Acción Histórica
De May 2024 a Jun 2024
Helix Biomedix (PK) (USOTC:HXBM)
Gráfica de Acción Histórica
De Jun 2023 a Jun 2024
